13F HOLDINGS REPORT
Saturn V Capital Management LLC
Quarter ended Q1 2025 · Filed May 15, 2025 · Accession 0001964437-25-000005
Total Value
$198.2M
Positions
21
Other Managers
0
Confidential Omitted
No
Holdings (21)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ASCENDIS PHARMA A/S | ASND | 199,264 | $31.1M | 15.67% |
| 2 | DISC MEDICINE INC | IRON | 518,177 | $25.7M | 12.98% |
| 3 | CG ONCOLOGY INC | CGON | 577,696 | $14.1M | 7.14% |
| 4 | XENON PHARMACEUTICALS INC | XENE | 413,711 | $13.9M | 7.00% |
| 5 | MERUS N V | N5749R100 | 323,211 | $13.6M | 6.87% |
| 6 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 343,849 | $13.4M | 6.78% |
| 7 | SYNDAX PHARMACEUTICALS INC | SNDX | 1,041,280 | $12.8M | 6.46% |
| 8 | CELCUITY INC | CELC | 1,093,677 | $11.1M | 5.58% |
| 9 | COGENT BIOSCIENCES INC | COGT | 1,480,020 | $8.9M | 4.47% |
| 10 | VAXCYTE INC | PCVX | 232,295 | $8.8M | 4.43% |
| 11 | AMYLYX PHARMACEUTICALS INC | AMLX | 2,426,436 | $8.6M | 4.33% |
| 12 | ARGENX SE | ARGX | 13,862 | $8.2M | 4.14% |
| 13 | CENTESSA PHARMACEUTICALS PLC | CNTA | 448,692 | $6.5M | 3.26% |
| 14 | OCULAR THERAPEUTIX INC | OCUL | 598,191 | $4.4M | 2.21% |
| 15 | CONTINEUM THERAPEUTICS INC | CTNM | 560,979 | $3.9M | 1.98% |
| 16 | ABIVAX SA | AAVXF | 552,926 | $3.5M | 1.74% |
| 17 | KALVISTA PHARMACEUTICALS INC | KALV | 255,060 | $2.9M | 1.49% |
| 18 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 116,353 | $2.4M | 1.20% |
| 19 | SILENCE THERAPEUTICS PLC | SLNCF | 732,463 | $2.1M | 1.04% |
| 20 | CRINETICS PHARMACEUTICALS IN | CRNX | 59,017 | $2.0M | 1.00% |
| 21 | INOZYME PHARMA INC | 45790W108 | 499,254 | $454,321 | 0.23% |